Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Ashley Jones

Surgical Critical Care Macon, GA Medical Doctor

NPI 1760710743 CMS profile 442204

840 Pine St Ste 750, Macon, GA 31201

Open in the dashboard

General payments

$14,015

149 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Ashley Jones of Macon, GA is reported in the CMS Open Payments database as having received $14,015 across 149 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 90th percentile of Surgical Critical Care profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,627 25
2024 General $1,504 15
2023 General $1,219 27
2022 General $1,770 27
2021 General $738 21
2020 General $4,659 20
2019 General $499 14

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ashley Jones
  • Surgical Critical Care median
  • Middle half of Surgical Critical Care
  • National median

In program year 2025, general payments to Ashley Jones were reported at $3,627. Among 1,068 Surgical Critical Care profiles paid that year, the median was $231 and the middle half received between $82 and $1,489.

Show as a table
Year Ashley Jones Surgical Critical Care median Middle half National median
2019 $499 $161 $57–$631 $163
2020 $4,659 $116 $33–$383 $114
2021 $738 $121 $37–$475 $132
2022 $1,770 $163 $53–$789 $149
2023 $1,219 $188 $67–$1,031 $160
2024 $1,504 $216 $80–$1,133 $164
2025 $3,627 $231 $82–$1,489 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Intuitive Surgical, Inc. $4,713 10 payments
  2. Penumbra, Inc. $2,553 9 payments
  3. Integra LifeSciences Corporation $2,020 19 payments
  4. Medical Device Business Services, Inc. $1,007 4 payments
  5. DePuy Synthes Sales Inc. $766 23 payments
  6. Aroa Biosurgery Incorporated $529 11 payments
  7. PolyNovo North America LLC $493 6 payments
  8. W. L. Gore & Associates, Inc. $293 3 payments
  9. Acell, Inc. $194 4 payments
  10. Ethicon US, LLC $160 9 payments
  11. Other $1,287 51 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $5,603 137 payments
  2. Education $4,000 1 payment
  3. Travel and Lodging $3,495 10 payments
  4. Long term medical supply or device loan $917 1 payment
Products named General payments · program years 2019–2025
  1. Da Vinci Surgical System $4,713 10 payments
  2. RUBY Coil $2,553 9 payments
  3. Integra Recon-Skin And Wound $1,765 12 payments
  4. Integra Recon-Skin And Wound $847 11 payments
  5. PRIMATRIX $847 11 payments
  6. Integra Recon-Skin And Wound $847 11 payments
  7. INTEGRA DERMAL REGENERATION TEMPLATE $847 11 payments
  8. MATRIXRIB $565 19 payments
  9. NOVOSORB BTM $493 6 payments
  10. Enseal $212 4 payments
  11. Other $3,525 114 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

18

Median for General Surgery: 59

Drug cost

$72

Median for General Surgery: $393

Branded share of claims

0%

Median for General Surgery: 28.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone Hcl Generic 18 $72

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 15,891 Part D prescribers listed as General Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 84 billing codes

Paid by Medicare

$53,691

Medicare's payments for the services billed

Medicare patients

254

Average age 73

Services billed

422

125 women, 129 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Chronic kidney disease 55%
Diabetes 52%
Arthritis 50%
Ischemic heart disease 46%
Heart failure 43%
Atrial fibrillation 36%
Depression 35%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

149 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgical Critical Care in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record